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The emerging field of data science requires skills in managing large datasets, novel analysis methods, rigorous statistical analysis, new ways to convey outcomes, and more. It is an area of increasing importance within science, technology, engineering, and math (STEM), and the United States will need many more data-savvy professionals by 2020. This evolving field offers the opportunity to narrow the gender gap in STEM. Berman and Bourne indicate that On August 7, the scientific community lost a trailblazer for women in science who was known for her tenacity in preventing thalidomide, a drug to treat morning sickness during pregnancy, from going on the market in the United States. Dr. Frances
Oldham Kelsey died in London, Canada, at 101 years of age.
Dr. Kelsey attended McGill University, where she received a B.Sc. and an M.Sc. in pharmacology. She then applied to do graduate work with E. M. K. Geiling, M.D., at the University of Chicago. Dr. Geiling accepted her application to work with him, presumably because he assumed she was a man. During her graduate training, Dr. Kelsey became interested in teratogens, drugs that cause defects in developing embryos. Upon completion of her graduate training, she joined the faculty at the University of Chicago, where she met her husband, Dr. Fremont Ellis Kelsey.
In 1960, Dr. Kelsey joined the Food and Drug Administration (FDA), where she was one of 11 physicians reviewing drugs for the agency. She was assigned to review the drug thalidomide (Kevadon), which was indicated for use by pregnant women to control morning sickness. At the time, the drug had already been approved for use in Canada and several European and African countries. Dr. Kelsey was concerned about a report that indicated that thalidomide caused nervous system side effects, so she asked for more information.
Despite significant pressure from the manufacturer, Dr. Kelsey insisted that the drug not be approved until further testing was conducted. Soon after, researchers found that thalidomide crossed the placental barrier and resulted in several birth defects. The Washington Post hailed Dr. Kelsey as a heroine and credited her with preventing birth defects in hundreds or thousands of infants. Dr. Kelsey's work contributed to the passing of the Kefauver Harris Amendments, which led to strengthened drug regulation, and she received the President's Award for Distinguished Federal Service from President John F. Kennedy for her work at the FDA. She was only the second woman to win the award.
Dr. Kelsey retired from the FDA in 2005 at the age of 90. In 2010, she was awarded the first FDA Drug Safety Excellence Award, which has been renamed the Kelsey Award. The award is given annually to an FDA employee in her honor.
Dr. Kelsey being awarded the President's Award for Distinguished Federal Civil Service by President John F. Kennedy in 1962
Institutional Spotlight: The University of North Carolina
The University of North Carolina (UNC) has been a leader in increasing the representation of women in senior leadership. In July 2013, UNC named Carol Folt, Ph.D., the first woman chancellor of the university. Additionally, three of five deans of schools on the UNC Health Affairs campus are women, and women occupy many leadership roles in the UNC School of Medicine. The university administration, faculty, and students take a multifaceted approach for increasing representation of women throughout the academic ranks. will include a greater number of universities. One of the group's key accomplishment is raising awareness on issues affecting the culture at multiple levels, including reaching young girls, undergraduate and graduate students, and faculty. When asked about the group's accomplishments, Dr. Verde said, "We are most proud of the Annual Symposium. It provides a unique training experience where advocates for equality can gather, gain career development skills, and most importantly create a professional peer network through which they can seek support and advice in years to come. It is
AMPWIS Founders Audrey Verde (left)
and Kate Hacker (right) a big step for the longevity of AMPWIS for the Symposium to be held at MUSC this year, and we hope to continue to expand it in years to come." For more information about AMPWIS, visit http://uncadvocatesformdphdwomeninscience.web.unc.edu.
In May 2012, the Women in Science and Engineering at UNC (UNC WISE), a discussion group dedicated to exploring the issues that women face in science, was formed. The group was started by graduate students in the UNC Department of Chemistry.
They now have representation from graduate students and postdoctoral fellows in a wide array of STEM (science, technology, engineering, and math) fields. The goal of UNC WISE is to bring scientists together to connect, generate ideas, share advice, and learn about problems caused by the disparity of success between female and male scientists, as well as about the inspirational work by female scientists. UNC WISE is both a discussion group and host of many professional development and outreach events, including events to promote networking, improve interviewing skills, and reach out to younger girls in the community, including classroom visits and science fairs. In 2015, UNC WISE partnered with the UNC Libraries and hosted a "Women in Science Wikipedia Edit-a-thon," where approximately 30 WISE members added or edited Wikipedia articles about women in science. Stephanie Murray, a third-year graduate student in the Department of Chemistry and a WISE executive board member, said, "It was really amazing to see how many female scientists either had pages that contained minimal information or did not have pages at all. It was a lot of work but very worthwhile to increase visibility of female scientists." UNC WISE is continuing to promote cross-talk between groups focused on women in the biomedical workforce. To learn more about UNC WISE, visit https://uncwise.wordpress.com.
These programs help show how UNC has made great strides in improving the representation of women throughout the biomedical workforce and provides numerous resources for women considering biomedical research careers.
WISE members participating in the UNC Wikipedia Edit-a-thon in April 2015

Years of Advancing Women in Science
NIH's Office of Research on Women's Health (ORWH) is celebrating its 25th anniversary this fall. Established in 1990, ORWH works to ensure that women are represented in scientific research and biomedical careers and also to support research related to the role of sex and gender in health. These issues are important for everyone.
Find out how ORWH and its NIH partners have supported careers of women in the biomedical workforce, from mentored career development programs, grant supplements that allow scientists to re-establish careers in the biomedical or behavioral sciences, and training support on the NIH campuses.
Follow ORWH on Twitter and Facebook for research updates and more. To find out about ORWH's 25th anniversary celebrations, please visit http://orwh.od.nih.gov/about/25anniversary.asp.
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Current News and Reports
NIH Reissues Funding Opportunity Announcement to Promote Reentry into the Biomedical and Behavioral Workforce
In August, NIH published the funding opportunity announcement "Research Supplements to Promote Reentry into Biomedical and Behavioral Research Careers (Admin Supp)." The goal of this program is to support a candidate by allowing them to reenter an active career following a qualifying circumstance (e.g., family care-giving responsibilities). This award supplements an active NIH research grant or cooperative agreement and supports full-or part-time research by the reentry scientist. Upon completion of the award, it is anticipated that the reentry scientist will be in a position to competitively apply for a career development award, a research award, or some other form of research support. 
Extramural Work: To Serve or not to Serve
Written by Roberta Kwok for Nature, July 30, 2015
http://www.nature.com/nature/journal/v523/n7562/full/nj7562-627a.html
Scientists commonly serve their institutions by joining committees to review research proposals, contributing to professional organizations, and helping universities foster strong research and student development. This work can have career benefits, but it also runs the risk of overburdening researchers. Also, many scientists may feel obligated to accept every committee request. For example, women or researchers from underrepresented minorities may be asked to serve on committees more often than their peers, in order to increase diversity, and may feel pressure to play a representative role. Kwok outlines ways for scientists to more strategically manage committee work and determine which committee positions to accept or decline.
